Ishita Drugs Peer Comparison

BSE: 524400

₹74.00

₹1.10 (1.51%)

As on 07-Sep-2026 13:48IST

Market cap

₹22 Cr

Revenue (TTM)

₹12 Cr

P/E Ratio

31.3

P/B Ratio

1.9

Div. Yield

0 %

Edit

	Ishita Drugs	Caplin Point Lab	Pfizer	Shilpa Medicare	Eris Lifesciences
Market cap (₹ Cr)	22	21,529	21,021	18,261	18,422
Revenue (₹ Cr)	12	2,287	2,570	1,682	3,230
Net Profit (₹ Cr)	0.71	678.07	735.15	273.51	666.92
Net Margin (%)	5.51	28.10	26.88	16.19	20.60
RoE (%)	6.19	19.73	19.16	11.15	18.75
Price to Earnings	31.34	32.36	28.59	61.42	28.61
Price-To-Book	1.88	5.86	4.77	6.80	4.57

Income Statement (₹ Cr)

	Ishita Drugs	Caplin Point Lab	Pfizer	Shilpa Medicare	Eris Lifesciences
Operating Revenue	12.40	2,287.33	2,569.77	1,682.47	3,229.67
Total Income	12.82	2,413.29	2,735.39	1,689.83	3,237.12
Total Expenditure	11.67	1,490.75	1,628.14	1,203.91	2,090.06
EBITDA	0.74	796.58	941.63	478.55	1,139.61
Depreciation	0.12	78.10	57.58	126.01	281.06
EBIT	0.62	718.48	884.05	352.55	858.55
Interest	0.04	0.88	7.69	52.11	190.64
Other Income	0.42	125.96	165.62	7.37	7.45
Exceptional Items	0.00	0.00	-49.16	12.16	-17.24
Profit before Tax	0.99	843.56	992.82	319.96	658.12
Provision for Tax	0.29	165.49	257.67	46.45	-8.80
Profit after Tax	0.71	678.07	735.15	273.51	666.92

	Ishita Drugs	Caplin Point Lab	Pfizer	Shilpa Medicare	Eris Lifesciences
Shareholder's Funds	11.57	3,586.42	4,202.90	2,591.20	3,902.67
Minority Interest	0.00	-12.71	0.00	0.00	-21.81
Non-Current Liabilities	0.05	28.74	91.50	266.35	1,392.75
Current Liabilities	0.99	385.94	627.48	848.06	2,077.10
Total Liabilities	16.30	3,207.85	4,911.11	3,310.68	6,865.52

	Ishita Drugs	Caplin Point Lab	Pfizer	Shilpa Medicare	Eris Lifesciences
Non-Current Assets	2.99	1,291.22	770.28	2,525.44	5,617.77
Current Assets	9.54	2,585.66	3,803.22	1,109.77	1,539.85
Total Assets	16.30	3,207.85	4,911.11	3,310.68	6,865.52
Total Debt*	3.90	0.55	2.50	586.37	2,421.66
Net Current Assets	8.55	2,199.72	3,175.74	261.71	-537.25
Contingent Liabilities	--	0.64	363.79	76.22	51.96

	Ishita Drugs	Caplin Point Lab	Pfizer	Shilpa Medicare	Eris Lifesciences
Cash From Operating Activities	-3.64	432.37	659.75	132.27	1,065.01
Cash Flow from Investing Activities	-0.67	-334.73	-71.34	-199.13	-79.97
Cash from Financing Activities	4.33	-38.32	-205.34	62.65	-881.32
Net Cash Inflow / Outflow	0.02	59.32	383.07	-4.21	103.72

	Ishita Drugs	Caplin Point Lab	Pfizer	Shilpa Medicare	Eris Lifesciences
ROCE (%)	9.97	26.22	26.21	6.95	13.59
ROE (%)	6.19	19.73	19.16	11.15	18.75
ROA (%)	4.89	18.69	14.95	7.80	9.26
EBIT Margin (%)	4.96	31.41	34.40	20.95	26.58
Net Margin (%)	5.51	28.10	26.88	16.19	20.60
Cash Profit Margin (%)	0.00	0.00	0.00	0.00	0.00

	Ishita Drugs	Caplin Point Lab	Pfizer	Shilpa Medicare	Eris Lifesciences
Revenue Growth (%)	-28.59	15.01	10.69	27.91	9.59
EBIT Growth (%)	-42.31	18.45	24.14	58.32	16.84
Net Profit Growth (%)	-30.99	19.61	-9.09	149.56	62.68
EPS Growth (%)	-30.99	17.73	14.40	-3.57	67.41
Book Value Growth (%)	8.75	23.77	17.30	30.63	10.19

	Ishita Drugs	Caplin Point Lab	Pfizer	Shilpa Medicare	Eris Lifesciences
Price / Earnings	30.88	32.11	27.36	67.34	27.87
Price / Book Value	1.85	5.82	4.79	7.03	4.56
Dividend Yield (%)	0.00	0.28	1.63	0.06	0.00
EV/EBITDA	23.55	25.55	19.11	40.72	18.10
Market Cap (₹ Cr)	23.49	15,219.80	18,318.10	6,484.12	19,292.77

	Ishita Drugs	Caplin Point Lab	Pfizer	Shilpa Medicare	Eris Lifesciences
Debt to Equity	0.00	0.00	0.00	0.07	0.24
Short term debt to equity ratio	0.35	0.00	0.00	0.13	0.14
Current Ratio	9.66	6.70	6.06	1.31	0.74
Quick Ratio	8.72	5.59	5.31	0.88	0.53
Interest Coverage	25.22	959.59	130.11	7.14	4.45

	Ishita Drugs	Caplin Point Lab	Pfizer	Shilpa Medicare	Eris Lifesciences
Debtors to sales (%)	8.13	36.10	7.07	30.84	21.07
Asset Turnover	0.86	0.63	0.52	0.48	0.45
Receivable days	31.60	110.70	29.10	118.15	54.06
Inventory Days	67.28	65.86	69.53	98.29	32.16
Payable days	24.37	105.88	76.77	128.16	140.91
Cash Conversion Cycle	74.52	70.68	21.86	88.28	-54.69

*TTM (Trailing Twelve Months) data based on income statement of last 4 quarters and interim half yearly balance sheet.